摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-甲氧基-联苯-4-羧酸 | 5783-36-8

中文名称
3-甲氧基-联苯-4-羧酸
中文别名
3'-甲氧基二苯基-4-羧酸,96%
英文名称
3'‐methoxy‐(1,1'‐biphenyl)‐4‐carboxylic acid
英文别名
3'-methoxy-[1,1'-biphenyl]-4-carboxylic acid;3'-methoxy-4-biphenylcarboxylic acid;3'-methoxy[1,1'-biphenyl]-4-carboxylic acid;3'-methoxybiphenyl-4-carboxylic acid;4-(3-methoxyphenyl)benzoic Acid
3-甲氧基-联苯-4-羧酸化学式
CAS
5783-36-8
化学式
C14H12O3
mdl
MFCD03424601
分子量
228.247
InChiKey
OAMJQKDGQYAQKD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    197-198℃
  • 沸点:
    399.4±25.0 °C(Predicted)
  • 密度:
    1.193±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.071
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2922299090

SDS

SDS:e1c507d629b7369b3087c16168e82304
查看
Material Safety Data Sheet

Section 1. Identification of the substance
4-(3-Methoxyphenyl)benzoic acid
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
4-(3-Methoxyphenyl)benzoic acid
Ingredient name:
CAS number: 5783-36-8

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C14H12O3
Molecular weight: 228.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    [EN] MYOSIN LIGHT CHAIN PHOSPHATASE INHIBITORS
    [FR] INHIBITEURS DE PHOSPHATASE DE CHAÎNE LÉGÈRE DE MYOSINE
    摘要:
    新型肌球蛋白轻链磷酸酶抑制剂,含有它们的组合物,制备和使用它们的方法,以及使用荧光肌球蛋白轻链磷酸酶抑制剂的方法被描述。
    公开号:
    WO2009146013A1
  • 作为产物:
    描述:
    4-(3-甲氧基苯基)苯甲酸乙酯sodium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 生成 3-甲氧基-联苯-4-羧酸
    参考文献:
    名称:
    Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa
    摘要:
    The discovery and some of the basic structure-activity relationships of a series of novel nonpeptide inhibitors of blood coagulation Factor Xa is described. These inhibitors are functionalized p-alanines, exemplified by 2a. Docking experiments placing 2a in the active site of Factor Xa implied that the Most expeditious route to enhancing in vitro potency was to modify the group occupying the S3 site of the enzyme. Increasing the hydrophobic contacts between the inhibitor and the enzyme in this region led to 8, which has served as the prototype for this series. In addition, an enantioselective synthesis of these substituted p-alanines was also developed.
    DOI:
    10.1021/jm970482y
点击查看最新优质反应信息

文献信息

  • Inhibitors of cathepsin S
    申请人:IRM LLC
    公开号:US20040198780A1
    公开(公告)日:2004-10-07
    The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme (e.g., cathespin K). The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.
    本发明提供了用于选择性抑制蛋白酶S的化合物、组合物和方法。在一个优选方面,当至少存在另一种蛋白酶同工酶(例如,蛋白酶K)时,选择性地抑制蛋白酶S。本发明还提供了通过选择性抑制蛋白酶S来治疗受试者疾病状态的方法。
  • Amidocarboxylic acid derivatives
    申请人:Sankyo Company, Limited
    公开号:US06528525B1
    公开(公告)日:2003-03-04
    Amidocarboxylic acid derivatives of the formula: wherein R1 represents a hydrogen atom, etc.; R2 represents an alkylene group; R3 represents a hydrogen atom, etc.; R4 represents a hydrogen atom, etc.; X represents a substituted or unsubstituted aryl group, etc.,; Y represents an oxygen atom, etc.; Z represents an alkylene group, etc.; and W represents an alkyl group, etc.; and pharmacologically acceptable salts thereof and pharmacologically acceptable esters thereof are useful as the active ingredient of pharmaceutical compositions. They may be used to treat specified diseases, including diabetes mellitus, hyperlipemia, arteriosclerosis, hypertension, etc.
    公式为:其中R1代表氢原子,等等;R2代表烷基团;R3代表氢原子,等等;R4代表氢原子,等等;X代表取代或未取代的芳基团,等等;Y代表氧原子,等等;Z代表烷基团,等等;W代表烷基团,等等;以及其药理学上可接受的盐和药理学上可接受的酯作为药物组合物的活性成分是有用的。它们可用于治疗特定疾病,包括糖尿病、高脂血症、动脉硬化、高血压等。
  • Microwave-assisted Negishi and Kumada cross-coupling reactions of aryl chloridesElectronic supplementary information (ESI) available: Experimental procedures and spectral data. See http://www.rsc.org/suppdata/cc/b3/b313887a/
    作者:Peter Walla、C. Oliver Kappe
    DOI:10.1039/b313887a
    日期:——
    Rapid Pd or Ni-catalyzed microwave-accelerated Negishi and Kumada cross-coupling reactions of aryl chlorides in solution and on solid phase are reported.
    报告了一种快速钯或镍催化的微波加速Negishi和Kumada交叉偶联反应,该反应在溶液中和固相上对芳基氯化物进行。
  • Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors
    作者:Michael S. Malamas、Shrouq I. Farah、Manjunath Lamani、Dimitrios N. Pelekoudas、Nicholas Thomas Perry、Girija Rajarshi、Christina Yume Miyabe、Honrao Chandrashekhar、Jay West、Spiro Pavlopoulos、Alexandros Makriyannis
    DOI:10.1016/j.bmc.2019.115195
    日期:2020.1
    inflammation and pain. Thus, blocking the degradation of PEA with NAAA inhibitors results in augmentation of the PEA/PPAR-α signaling pathway and regulation of inflammatory and pain processes. We have prepared a new series of NAAA inhibitors exploring the azetidine-nitrile (cyanamide) pharmacophore that led to the discovery of highly potent and selective compounds. Key analogs demonstrated single-digit nanomolar
    N-酰基乙醇胺酸酰胺酶(NAAA)抑制代表了一种激动人心的新颖方法,用于治疗炎症和疼痛。NAAA是半胱氨酸酰胺酶,可优先水解内源性生物脂质棕榈酰乙醇酰胺(PEA)和油酰乙醇酰胺(OEA)。PEA是核过氧化物酶体增殖物激活受体-α(PPAR-α)的内源性激动剂,PPAR-α是炎症和疼痛的关键调节剂。因此,用NAAA抑制剂阻止PEA的降解会导致PEA /PPAR-α信号传导途径的增强以及炎症和疼痛过程的调节。我们准备了一系列新的NAAA抑制剂,用于研究氮杂环丁烷-腈(氰胺)药效团,从而发现了高效且选择性强的化合物。关键类似物显示出hNAAA的一位数纳摩尔效价,并显示> 对丝氨酸水解酶FAAH,MGL和ABHD6和半胱氨酸蛋白酶组织蛋白酶K的选择性是100倍。此外,我们已经确定了有效的和选择性的双重NAAA-FAAH抑制剂来研究两种不同的抗炎分子途径PEA / PPAR之间的潜在协同作用-α抗炎
  • Poly(o-aminothiophenol)-stabilized Pd nanoparticles as efficient heterogenous catalysts for Suzuki cross-coupling reactions
    作者:Yuan Chen、Minggui Wang、Long Zhang、Yan Liu、Jie Han
    DOI:10.1039/c7ra09947a
    日期:——
    surfactant. The redox reaction between o-aminothiophenol and Pd(NO3)2 leads to the simultaneous formation of a PATP polymer and Pd nanoparticles. The PATP-stabilized Pd nanoparticles have been characterized by TEM, FTIR, XRD, ICP-MS and XPS. Catalytic results showed that PATP-stabilized Pd nanoparticles were highly stable and active catalysts for Suzuki cross-coupling reactions, where high yields could
    聚(Ô -aminothiophenol)(PATP) -稳定的钯纳米粒子与钯纳米粒子包埋在聚合物基质已通过混合通过一个浅显一步法途径获得ö -aminothiophenol单体和Pd(NO 3)2在酸性水溶液中,而不其他模板或表面活性剂。邻氨基苯硫酚与Pd(NO 3)2的氧化还原反应导致同时形成PATP聚合物和Pd纳米颗粒。通过TEM,FTIR,XRD,ICP-MS和XPS对PATP稳定的Pd纳米颗粒进行了表征。催化结果表明,PATP稳定的Pd纳米颗粒是铃木交叉偶联反应的高度稳定和活性催化剂,其中芳基硼酸和带有多种取代基的芳基卤化物可以实现高收率。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐